SHPG
Shire Plc
A specialty biopharmaceutical company that made medicines for rare diseases and complex conditions, including the ADHD drugs Vyvanse and Adderall XR and treatments for hemophilia. It began in 1986 in a small Hampshire shop as AimCane, selling calcium products for osteoporosis, and later took the name "Shire" from the building that housed its early offices. In 2019 it was acquired by Takeda and folded into that company.
ADRUnderlying: SHPGCUSIP: 82481R106HealthcareGB5 holders
Sponsored American Depositary Receipt — Acquired by Takeda Pharmaceutical, delisted Jan 2019